Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02947737 · ClinicalTrials.gov registry record · NA
Amniotic Membrane for Donor Site Healing
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02947737 is a NA study that has completed, run by Emory University. The registered enrollment target is 4 participants.
The verdict
NCT02947737, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of applying amniotic membrane dressings compared to gentamicin and xeroform dressings to donor sites for skin grafts. This study will enroll ten participants who undergoing a split thickness skin graft procedure with two or more donor sites. The amniotic membrane will be applied to one donor site and a dressing of xeroform and gentamicin will be applied to another other donor site. Each participant will receive both types of dressing and will serve as their own control. Postoperative follow up will follow standard of care, regardless of the dressing type. Dressings will be removed on postoperative day 4 and participants will return to be re-examined one week after being discharged from the hospital.
Interventions
- OTHER Amniotic membrane dressing
- OTHER Gentamicin and xeroform dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02947737
The ClinicalTrials.gov registry entry for NCT02947737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amniotic membrane dressing is the first listed.
NCT02947737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02947737 about?
NCT02947737 is a clinical study titled "Amniotic Membrane for Donor Site Healing". The purpose of this study is to compare the effectiveness of applying amniotic membrane dressings compared to gentamicin and xeroform dressings to donor sites for skin grafts. This study will enroll ten participants who undergoing a split thickness skin graft procedure with two or more donor sites. ...
What is the current status of trial NCT02947737?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-02-01. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT02947737?
The interventions under investigation include: Amniotic membrane dressing (OTHER), Gentamicin and xeroform dressing (OTHER).
Who is sponsoring clinical trial NCT02947737?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.